Multifunctional human serum albumin-therapeutic nucleotide conjugate with redox and pH-sensitive drug release mechanism for cancer theranostics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	3925-3930
Number of pages	6
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	27
Issue number	16
DOIs	https://doi.org/10.1016/j.bmcl.2017.05.084
Publication status	Published - 15 Aug 2017

Dual-responsive drug release, Modified human serum albumin, Multimodal molecular imaging, Theranostic prodrug, Trifluorothymidine conjugate, Oxidation-Reduction, Serum Albumin/chemistry, Humans, Structure-Activity Relationship, Antineoplastic Agents/chemical synthesis, Dose-Response Relationship, Drug, Nucleotides/chemistry, Cell Line, Tumor, Thymine Nucleotides/chemistry, Molecular Structure, Cell Proliferation/drug effects, Drug Screening Assays, Antitumor, Hydrogen-Ion Concentration, ACTIVATION, THYMIDYLATE SYNTHASE, TRIFLUOROTHYMIDINE, INNOVATION, DELIVERY, INHIBITION, SOLID TUMORS, CHEMOTHERAPY, GEMCITABINE, TAS-102

ID: 8688654